Want to join the conversation?
Pharmaceutical companies, $AMGN and $AGN today announced that a Phase 3 study of biosimilar candidate ABP 215 met its primary and secondary endpoints. The study assess the safety and efficacy of ABP 215 when compared with Avastin (bevacizumab) in adult patients suffering from advanced non-squamous non-small cell lung cancer (NSCLC).
$AAL is giving pay hikes to its employees but investors are sulking.
$APC stock tumbled more than 5.6% after last week's fatal home explosion in Firestone, Colorado prompted the company to close more than 3,000 wells for weeks.
Unicorn Frappuccino. The latest hit from $SBUX. Can't wait to see how this will affect its results.
At what point should $AMZN consider a stock split? $1000 per share seems pretty high.